Sign in
0AAJ Stock Price, Chart, Stats & News
PolyPeptide Group AG
Save
PolyPeptide Group AG (0AAJ) does not currently pay a dividend.
1.45B
Market cap
–
Current P/E
–
Forward P/E
0AAJ chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
Operating globally, PolyPeptide Group AG functions as a prominent contract development and manufacturing organization (CDMO). The company specializes in producing both proprietary and generic GMP-certified peptides, which are supplied to pharmaceutical and biotechnology firms. These crucial components are integrated into approved pharmaceutical products, drugs in various stages of clinical development, and generic medications.
Similar securities
Based on sector and market capitalization
Report issue